SUSAN MCGREW, MD
Medical Practice in Nashville, TN
License number
Tennessee MD18755
Category
Medical Practice
Type
Pediatrics
Address
Address
3601 Tvc, Nashville, TN 37232
Phone
(615) 322-3000
Personal information
See more information about SUSAN MCGREW at radaris.comName
Address
Phone
703 Lynnwood Blvd, Nashville, TN 37205
1440 Sneed Rd W, Franklin, TN 37069
1029 Bowwood Dr, Nashville, TN 37217
1029 Boxwood Dr, Franklin, TN 37069
Nashville, TN
Organization information
See more information about SUSAN MCGREW at bizstanding.comSusan McGrew MD
703 Lynnwood Blvd, Nashville, TN 37205
Industry:
Pediatrician
Phone:
(615) 322-3000 (Phone)
Susan Goshgarian Mcgrew
Professional information
See more information about SUSAN MCGREW at trustoria.com
Regional Public Sector Account Manager At Sprint
Regional Public Sector Account Manager At Sprint
Position:
Regional Public Sector Account Manager at Sprint
Location:
Greater Nashville Area
Industry:
Telecommunications
Work:
Sprint
-
Regional Public Sector Account Manager
Education:
David Lipscomb University 1975 - 1978
Regional Government Account Manager At Sprint
Regional Government Account Manager At Sprint
Location:
Greater Nashville Area
Industry:
Wireless
Regional Government Account Manager At Sprint
Regional Government Account Manager At Sprint
Location:
Greater Nashville Area
Industry:
Telecommunications
Modulation Of In Vivo Glutamine And Glycine Levels In The Treatment Of Autism
Modulation Of In Vivo Glutamine And Glycine Levels In The Treatment Of Autism
US Patent:
2001004, Nov 22, 2001
Filed:
Dec 5, 2000
Appl. No.:
09/729881
Inventors:
John Phillips - Brentwood TN, US
Susan McGrew - Nashville TN, US
Susan McGrew - Nashville TN, US
International Classification:
A61K031/485
US Classification:
514/282000
Abstract:
A method of treating autism in a patient. The method includes administering to the patient an effective amount of a glutamine level reducing agent, a glycine level reducing agent or combinations thereof. Representative glutamine level reducing agents are phenylbutyrate and phenylacetate, and a representative glycine level reducing agent is sodium benzoate. Optionally, an N-methyl-D-aspartate receptor antagonist can also be administered to the patient. A representative N-methyl-D-aspartate receptor antagonist is dextromethorphan.